Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

HCA Healthcare Inc (HCA.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (US$)	Price Target (US$)	Rating
2022-04-08	258.69	289.00	Buy
2022-04-25	210.50	241.00	Buy
2022-06-27	179.82	207.00	Buy
2022-07-25	198.63	227.00	Buy
2022-10-24	210.36	237.00	Buy
2022-12-21	242.90	-	No Rating
2023-01-12	255.15	296.00	Buy
2023-05-19	282.47	325.00	Buy
2023-07-28	273.25	323.00	Buy
2023-10-25	225.36	305.00	Buy
2024-01-30	301.59	348.00	Buy
2024-04-29	311.42	363.00	Buy
2024-05-20	325.05	377.00	Buy
2024-07-23	340.17	405.00	Buy
2024-08-14	371.58	438.00	Buy

Disclosures

UBS Securities LLC makes a market in the securities and/or ADRs of this company.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.